Takeda Pharmaceutical TAK
NYSE TAK
$18.19 -0.33 (-1.78%)
At close: Sep 30, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Net Cash Flow (2018 - 2026)

Updated

Takeda Pharmaceutical (TAK) reported Net Cash Flow of $250.45 million for the quarter ended Jun 30, 2026, down 80.1% from $1.26 billion a year earlier and down 75.0% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Net Cash Flow (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Takeda Pharmaceutical's Net Cash Flow came in at $8.42 billion, down 10.4% year-over-year; for the year ended Mar 31, 2026, it was $1.17 billion.

  • By year, Net Cash Flow came in at -$402.44 million in the year ended Mar 31, 2025, -$706.82 million in the year ended Mar 31, 2024, -$2.51 billion in the year ended Mar 31, 2023 and -$1.29 billion in the year ended Mar 31, 2022.
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Net Cash Flow since the quarter ended Jun 30, 2024.
  • Year over year, Net Cash Flow has now declined in each of the last three quarters, with growth averaging 33.6% over the last six quarters.
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $1 billion (quarter ended Mar 31, 2026), $932.15 million (quarter ended Dec 31, 2025) and $6.24 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -1.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 757.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -4.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -722.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 652.90 Mn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn 250.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 250.45 Mn
Mar 31, 2026 1.00 Bn
Dec 31, 2025 932.15 Mn
Sep 30, 2025 6.24 Bn
Jun 30, 2025 1.26 Bn
Mar 31, 2025 1.28 Bn
Dec 31, 2024 1.76 Bn
Sep 30, 2024 5.09 Bn
Jun 30, 2024 87.44 Mn
Mar 31, 2024 341.39 Mn
Dec 31, 2023 -179.81 Mn
Sep 30, 2023 3.34 Bn
Jun 30, 2023 -1.69 Bn
Mar 31, 2023 -2.67 Bn
Dec 31, 2022 -732.01 Mn
Sep 30, 2022 4.84 Bn
Jun 30, 2022 -1.75 Bn
Mar 31, 2022 -2.92 Bn
Jun 30, 2021 -2.87 Bn
Mar 31, 2021 272.35 Mn
API Access

Takeda Pharmaceutical Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=TAK&period=max&api_key=YOUR_API_KEY